(Q35704839)

English

Imatinib mesylate (STI571) for myeloid malignancies other than CML.

scientific article published on May 2004

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

Europe PubMed Central

title

Imatinib mesylate (STI571) for myeloid malignancies other than CML. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

Geoffrey W Krystal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15036942

retrieved

9 August 2017

publication date

1 May 2004

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

15036942

retrieved

9 August 2017

volume

28 Suppl 1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15036942

retrieved

9 August 2017

page(s)

S53-9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15036942

retrieved

9 August 2017

Identifiers

DOI

10.1016/J.LEUKRES.2003.10.003

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15036942

retrieved

9 August 2017

Fatcat ID

release_u5ng5me5srastpe2vsio5m4m4u

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/u5ng5me5srastpe2vsio5m4m4u

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

15036942

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15036942

retrieved

9 August 2017

(Q35704839)

Imatinib mesylate (STI571) for myeloid malignancies other than CML.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)